Further studies on the ribonuclease inhibitor from rat liver: stability and other properties.
D000818:Animals; D004355:Drug Stability; D004492:Edetic Acid; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008274:Magnesium; D009994:Osmolar Concentration; D010179:Pancreas / Q000201:enzymology; D010447:Peptide Hydrolases; D011506:Proteins; D051381:Rats; D012260:Ribonucleases / Q000037:antagonists & inhibitors*; D012965:Sodium Chloride; D013438:Sulfhydryl Compounds; D013997:Time Factors
D011506:Proteins; D013438:Sulfhydryl Compounds; D012965:Sodium Chloride; D004492:Edetic Acid; D012260:Ribonucleases; D010447:Peptide Hydrolases; D008274:Magnesium